✦ LIBER ✦

Antifibrotic Agents for Liver Disease

✍ Scribed by E. Albanis; S. L. Friedman

Book ID: 114803726
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 213 KB
Volume: 6
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2005.01143.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifibrotic therapy in chronic liver di

Antifibrotic therapy in chronic liver disease

✍ Rockey, Don C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 202 KB

M1571 Relaxin: An Antifibrotic Hormone i

M1571 Relaxin: An Antifibrotic Hormone in Patients with Liver Disease

✍ Channabasappa, Nandini; Mayo, Marlyn J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Antioxidants as therapeutic agents for l

Antioxidants as therapeutic agents for liver disease

✍ Ashwani K. Singal; Sarat C. Jampana; Steven A. Weinman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

New Therapies in Hepatitis C Virus and C

New Therapies in Hepatitis C Virus and Chronic Liver Disease: Antifibrotics

✍ Rockey, Don C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Hepatoprotective Agents in Alcoholic Liv

Hepatoprotective Agents in Alcoholic Liver Disease

✍ MORGAN, MARSHA Y. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 531 KB

Targeting liver fibrosis: Strategies for

Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

✍ Yury Popov; Detlef Schuppan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 1 views

We have made striking progress in our understanding of the biochemistry and cell biology that underlies liver fibrosis and cirrhosis, including the development of strategies and agents to prevent and reverse fibrosis. However, translation of this knowledge into clinical practice has been hampered by